世界の肥満管理市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV04028)
◆英語タイトル:Global Obesity Management Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV04028
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:99
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは肥満管理の世界市場について調査・分析した資料です。種類別(薬物、手術)の市場規模、用途別(病院、専門クリニック、外来外科センター、小売薬局)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別肥満管理の競争状況、市場シェア
・世界の肥満管理市場:種類別市場規模 2015年-2020年(薬物、手術)
・世界の肥満管理市場:種類別市場規模予測 2021年-2026年(薬物、手術)
・世界の肥満管理市場:用途別市場規模 2015年-2020年(病院、専門クリニック、外来外科センター、小売薬局)
・世界の肥満管理市場:用途別市場規模予測 2021年-2026年(病院、専門クリニック、外来外科センター、小売薬局)
・北米の肥満管理市場分析:米国、カナダ
・ヨーロッパの肥満管理市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの肥満管理市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の肥満管理市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの肥満管理市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Roche、GlaxoSmithKline、Orexigen Therapeutics、Arena Pharmaceuticals、VIVUS、Novo Nordisk
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Lifestyle diseases such as diabetes and other chronic ailments are the main cause of obesity around the world. Improved healthcare and medical facilities have led to an increase in the life expectancy of people, which is the primary reason for the large geriatric population seen in the developed world. Geriatric people are far more prone to conceal sarcopenia i.e. a noticeable rise in body fat with simultaneous loss of muscle mass and functional capability.
North America is forecast to account for more than 1/3 revenue share of the global obesity management market by 2017 and it should gain a substantial 224 BPS by the year 2025.

Market Analysis and Insights: Global Obesity Management Market
The global Obesity Management market size is projected to reach US$ 5820.4 million by 2026, from US$ 5535.3 million in 2020, at a CAGR of 4.8%% during 2021-2026.

Global Obesity Management Scope and Market Size
Obesity Management market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Obesity Management market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Roche
GlaxoSmithKline
Orexigen Therapeutics
Arena Pharmaceuticals
VIVUS
Novo Nordisk

Market segment by Type, the product can be split into
Drug
Surgery
Market segment by Application, split into
Hospitals
Speciality Clinics
Ambulatory Surgical Centres
Retail Pharmacies

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Obesity Management Revenue
1.4 Market by Type
1.4.1 Global Obesity Management Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Drug
1.4.3 Surgery
1.5 Market by Application
1.5.1 Global Obesity Management Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Speciality Clinics
1.5.4 Ambulatory Surgical Centres
1.5.5 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Obesity Management Market Perspective (2015-2026)
2.2 Global Obesity Management Growth Trends by Regions
2.2.1 Obesity Management Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Obesity Management Historic Market Share by Regions (2015-2020)
2.2.3 Obesity Management Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Obesity Management Market Growth Strategy
2.3.6 Primary Interviews with Key Obesity Management Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Obesity Management Players by Market Size
3.1.1 Global Top Obesity Management Players by Revenue (2015-2020)
3.1.2 Global Obesity Management Revenue Market Share by Players (2015-2020)
3.1.3 Global Obesity Management Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Obesity Management Market Concentration Ratio
3.2.1 Global Obesity Management Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Obesity Management Revenue in 2019
3.3 Obesity Management Key Players Head office and Area Served
3.4 Key Players Obesity Management Product Solution and Service
3.5 Date of Enter into Obesity Management Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Obesity Management Historic Market Size by Type (2015-2020)
4.2 Global Obesity Management Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Obesity Management Market Size by Application (2015-2020)
5.2 Global Obesity Management Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Obesity Management Market Size (2015-2020)
6.2 Obesity Management Key Players in North America (2019-2020)
6.3 North America Obesity Management Market Size by Type (2015-2020)
6.4 North America Obesity Management Market Size by Application (2015-2020)

7 Europe
7.1 Europe Obesity Management Market Size (2015-2020)
7.2 Obesity Management Key Players in Europe (2019-2020)
7.3 Europe Obesity Management Market Size by Type (2015-2020)
7.4 Europe Obesity Management Market Size by Application (2015-2020)

8 China
8.1 China Obesity Management Market Size (2015-2020)
8.2 Obesity Management Key Players in China (2019-2020)
8.3 China Obesity Management Market Size by Type (2015-2020)
8.4 China Obesity Management Market Size by Application (2015-2020)

9 Japan
9.1 Japan Obesity Management Market Size (2015-2020)
9.2 Obesity Management Key Players in Japan (2019-2020)
9.3 Japan Obesity Management Market Size by Type (2015-2020)
9.4 Japan Obesity Management Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Obesity Management Market Size (2015-2020)
10.2 Obesity Management Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Obesity Management Market Size by Type (2015-2020)
10.4 Southeast Asia Obesity Management Market Size by Application (2015-2020)

11 India
11.1 India Obesity Management Market Size (2015-2020)
11.2 Obesity Management Key Players in India (2019-2020)
11.3 India Obesity Management Market Size by Type (2015-2020)
11.4 India Obesity Management Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Obesity Management Market Size (2015-2020)
12.2 Obesity Management Key Players in Central & South America (2019-2020)
12.3 Central & South America Obesity Management Market Size by Type (2015-2020)
12.4 Central & South America Obesity Management Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview
13.1.3 Roche Obesity Management Introduction
13.1.4 Roche Revenue in Obesity Management Business (2015-2020))
13.1.5 Roche Recent Development
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Details
13.2.2 GlaxoSmithKline Business Overview
13.2.3 GlaxoSmithKline Obesity Management Introduction
13.2.4 GlaxoSmithKline Revenue in Obesity Management Business (2015-2020)
13.2.5 GlaxoSmithKline Recent Development
13.3 Orexigen Therapeutics
13.3.1 Orexigen Therapeutics Company Details
13.3.2 Orexigen Therapeutics Business Overview
13.3.3 Orexigen Therapeutics Obesity Management Introduction
13.3.4 Orexigen Therapeutics Revenue in Obesity Management Business (2015-2020)
13.3.5 Orexigen Therapeutics Recent Development
13.4 Arena Pharmaceuticals
13.4.1 Arena Pharmaceuticals Company Details
13.4.2 Arena Pharmaceuticals Business Overview
13.4.3 Arena Pharmaceuticals Obesity Management Introduction
13.4.4 Arena Pharmaceuticals Revenue in Obesity Management Business (2015-2020)
13.4.5 Arena Pharmaceuticals Recent Development
13.5 VIVUS
13.5.1 VIVUS Company Details
13.5.2 VIVUS Business Overview
13.5.3 VIVUS Obesity Management Introduction
13.5.4 VIVUS Revenue in Obesity Management Business (2015-2020)
13.5.5 VIVUS Recent Development
13.6 Novo Nordisk
13.6.1 Novo Nordisk Company Details
13.6.2 Novo Nordisk Business Overview
13.6.3 Novo Nordisk Obesity Management Introduction
13.6.4 Novo Nordisk Revenue in Obesity Management Business (2015-2020)
13.6.5 Novo Nordisk Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Roche、GlaxoSmithKline、Orexigen Therapeutics、Arena Pharmaceuticals、VIVUS、Novo Nordisk

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の肥満管理市場2026:インサイト・予測(Global Obesity Management Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。